Capricor Therapeutics (CAPR) P/E (2010 - 2026)
Capricor Therapeutics (CAPR) P/E from Dec 31, 2010 to Jun 2, 2026. The TTM Capricor Therapeutics (CAPR) P/E is -12.32. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Capricor Therapeutics (CAPR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -12.32 | -7.60% |
| 2025 | -13.34 | +8.36% |
| 2024 | -12.31 | +188.59% |
| 2023 | -4.26 | +24.56% |
| 2022 | -3.42 | -0.55% |
| 2021 | -3.44 | -19.74% |
| 2020 | -4.29 | +1796.03% |
| 2019 | -0.23 | -51.21% |
| 2018 | -0.46 | -74.05% |
| 2017 | -1.79 | -40.60% |
| 2016 | -3.01 | -22.49% |
| 2015 | -3.88 | -45.07% |
| 2014 | -7.07 | +3.07% |
| 2013 | -6.85 | -75.65% |
| 2012 | -28.15 | -88.11% |
| 2011 | -236.80 | -76.62% |
| 2010 | -1.01K | N/A |
Comparison Capricor Therapeutics (CAPR) P/E with competitors
Capricor Therapeutics (CAPR) P/E is -12.32.